Trihale 100 Rotacap
Trihale 100 Rotacap Original price was: 700.00৳ .Current price is: 665.00৳ .
Back to products
Trilock 10mg Tablet
Trilock 10mg Tablet Original price was: 238.00৳ .Current price is: 226.10৳ .
-5%
Click to enlarge

Trihale 200 Rotacap

SKU: 3784

Manufacturer: Acme Laboratories Ltd.

Generic: Vilanterol Trifenatate + Fluticasone Furoate + Umeclidinium Bromide

Type: Capsule

Pack Size: 10 Pcs

Apple Shopping Event

Hurry and get discounts on all Apple devices up to 20%

Sale_coupon_15

Original price was: 900.00৳ .Current price is: 855.00৳ .

Compare
Add to wishlist

Description

Vilanterol Trifenatate 25 mcg + Fluticasone Furoate 200 mcg + Umeclidinium Bromide 62.5 mcg is used for the Treatment of Chronic obstructive pulmonary disease (COPD) and AsthmaBefore using, always check the label for instructions. Trihale 200 Rotacap is intended for oral inhalation only. Use it as directed by your doctor, following the prescribed dose and duration. Keep the inhaler closed until you’re ready to use it. Shaking the inhaler is unnecessary and should be avoided. After inhaling, rinse your mouth with water and spit it out to help prevent fungal infections in the mouth and throat. Do not use more than once every 24 hours.

Each inhaler capsule contains:

  • Vilanterol 25 mcg (as Vilanterol Trifenatate INN), Fluticasone Furoate INN 100 mcg, and Umeclidinium 62.5 mcg (as Umeclidinium Bromide INN).
  • Vilanterol 25 mcg (as Vilanterol Trifenatate INN), Fluticasone Furoate INN 200 mcg, and Umeclidinium 62.5 mcg (as Umeclidinium Bromide INN).
Pack Image of Trihale 25 mcg Inhalation Capsule
This inhalation powder contains a combination of fluticasone furoate (a corticosteroid), umeclidinium (an anticholinergic), and vilanterol (a long-acting beta-agonist, or LABA). Vilanterol’s bronchodilatory effect is largely due to stimulation of adenyl cyclase, which increases cyclic AMP, relaxing bronchial muscles and inhibiting hypersensitivity mediators. Fluticasone furoate’s mechanism is not fully understood but reduces inflammation—a key factor in COPD and asthma—by acting on various cell types and mediators involved in inflammatory processes. Umeclidinium, a long-acting muscarinic antagonist, blocks M3 receptors in airway smooth muscle, leading to bronchodilation.